<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for The Ardleigh Surgery</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=practice+F81044">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where The Ardleigh Surgery is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0601023AU&amp;denomIds=6.1.2&amp;selectedTab=summary">Ins degludec/liraglutide</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>26</td>&#13;
      <td>Other antidiabetic drugs</td>&#13;
      <td>598</td>&#13;
      <td>0.04</td>&#13;
      <td>0.00</td>&#13;
      <td>0.01</td>&#13;
      <td>7.93</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0601023AUBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Xultophy 100units/ml / 3.6mg/ml inj 3ml pre-filled pens : 26</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0105010C0&amp;denomIds=1.5.1&amp;selectedTab=summary">Olsalazine sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>24</td>&#13;
      <td>Aminosalicylates</td>&#13;
      <td>224</td>&#13;
      <td>0.11</td>&#13;
      <td>0.00</td>&#13;
      <td>0.01</td>&#13;
      <td>7.49</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0105010C0AAADAD&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Olsalazine 500mg tablets : 24</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=1104020AE&amp;denomIds=11.4.2&amp;selectedTab=summary">Ciclosporin (Eye Anti Inflammatory)</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>15</td>&#13;
      <td>Other anti-inflammatory preparations</td>&#13;
      <td>32</td>&#13;
      <td>0.47</td>&#13;
      <td>0.05</td>&#13;
      <td>0.07</td>&#13;
      <td>6.19</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=1104020AEBBAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Ikervis 0.1% eye drops 0.3ml unit dose : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=1104020AEAAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Ciclosporin 0.1% eye drops 0.3ml unit dose : 14</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0601012Z0&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin degludec</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>167</td>&#13;
      <td>Intermediate and long-acting insulins</td>&#13;
      <td>297</td>&#13;
      <td>0.56</td>&#13;
      <td>0.10</td>&#13;
      <td>0.07</td>&#13;
      <td>6.18</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0601012Z0BBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Tresiba FlexTouch 100units/ml inj 3ml pre-filled pens : 113</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0601012Z0BBACAC&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Tresiba FlexTouch 200units/ml inj 3ml pre-filled pens : 51</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0601012Z0BBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Tresiba Penfill 100units/ml inj 3ml cartridges : 3</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0107010S0&amp;denomIds=1.7.1&amp;selectedTab=summary">Sucralfate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Soothing haemorrhoidal preparations</td>&#13;
      <td>9</td>&#13;
      <td>0.11</td>&#13;
      <td>0.00</td>&#13;
      <td>0.02</td>&#13;
      <td>5.78</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0107010S0AAAKAK&amp;denomIds=1.7.1&amp;selectedTab=summary" target="_blank">Sucralfate 2g/20ml enema : 1</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where The Ardleigh Surgery is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0206020A0&amp;denomIds=2.6.2&amp;selectedTab=summary">Amlodipine</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1396</td>&#13;
      <td>Calcium-channel blockers</td>&#13;
      <td>3252</td>&#13;
      <td>0.43</td>&#13;
      <td>0.75</td>&#13;
      <td>0.11</td>&#13;
      <td>-2.87</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0206020A0AAAAAA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 5mg tablets : 881</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0206020A0AAABAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 10mg tablets : 515</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0407041T0&amp;denomIds=4.7.4&amp;selectedTab=summary">Sumatriptan succinate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>92</td>&#13;
      <td>Treatment of acute migraine</td>&#13;
      <td>254</td>&#13;
      <td>0.36</td>&#13;
      <td>0.67</td>&#13;
      <td>0.12</td>&#13;
      <td>-2.50</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0407041T0AAAFAF&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Sumatriptan 50mg tablets : 52</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0407041T0AAAHAH&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Sumatriptan 10mg/0.1ml nasal spray unit dose : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0407041T0BBAIAF&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Imigran Radis 50mg tablets : 9</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0407041T0BBAFAF&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Imigran 50mg tablets : 4</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0407041T0BBAJAC&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Imigran Radis 100mg tablets : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0407041T0AAACAC&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Sumatriptan 100mg tablets : 19</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0205040D0&amp;denomIds=2.5.4&amp;selectedTab=summary">Doxazosin mesilate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>370</td>&#13;
      <td>Alpha-adrenoceptor blocking drugs</td>&#13;
      <td>391</td>&#13;
      <td>0.95</td>&#13;
      <td>0.99</td>&#13;
      <td>0.02</td>&#13;
      <td>-2.24</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0205040D0AAAAAA&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 1mg tablets : 94</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0205040D0AAABAB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 2mg tablets : 83</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0205040D0AAACAC&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg tablets : 176</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0205040D0AABBBB&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 8mg tablets : 1</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0205040D0AAAQAQ&amp;denomIds=2.5.4&amp;selectedTab=summary" target="_blank">Doxazosin 4mg modified-release tablets : 16</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0102000N0&amp;denomIds=1.2&amp;selectedTab=summary">Hyoscine butylbromide</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>12</td>&#13;
      <td>Antispasmodic and other drugs altering gut motility</td>&#13;
      <td>179</td>&#13;
      <td>0.07</td>&#13;
      <td>0.33</td>&#13;
      <td>0.12</td>&#13;
      <td>-2.23</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0102000N0AAABAB&amp;denomIds=1.2&amp;selectedTab=summary" target="_blank">Hyoscine butylbromide 10mg tablets : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=0102000N0BBAAAB&amp;denomIds=1.2&amp;selectedTab=summary" target="_blank">Buscopan 10mg tablets : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=1104020T0&amp;denomIds=11.4.2&amp;selectedTab=summary">Sodium cromoglicate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>9</td>&#13;
      <td>Other anti-inflammatory preparations</td>&#13;
      <td>32</td>&#13;
      <td>0.28</td>&#13;
      <td>0.67</td>&#13;
      <td>0.18</td>&#13;
      <td>-2.12</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=F81044&amp;numIds=1104020T0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Sodium cromoglicate 2% eye drops : 9</a></div></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>